Antibody‒cell conjugates: A novel “off-the-shelf” modality bridging ADCs and CAR-T for cancer immunotherapy
Acta Pharmaceutica Sinica B · 2026-10 · 16 (10) · 6360-6377
DOI: 10.1016/j.apsb.2026.07.034 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-10. Verfasst von Yifei Dai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Yangtze River Delta Center for Drug Evaluation and Inspection of The National Medical Products Administration, Shanghai 201210, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Yangtze River Delta Center for Drug Evaluation and Inspection of The National Medical Products Administration, Shanghai 201210, China.
- Department of Cardiology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China.
- Department of Pulmonary and Critical Care Medicine, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200120, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Dai, Y., Xie, Y., Ma, X., Zhang, D., Yang, J., Lin, K., Chen, A., & Qiang, W. (2026). Antibody‒cell conjugates: A novel “off-the-shelf” modality bridging ADCs and CAR-T for cancer immunotherapy. Acta Pharmaceutica Sinica B, 16(10), 6360-6377. https://doi.org/10.1016/j.apsb.2026.07.034
Vancouver
Dai Y, Xie Y, Ma X, Zhang D, Yang J, Lin K, et al. Antibody‒cell conjugates: A novel “off-the-shelf” modality bridging ADCs and CAR-T for cancer immunotherapy. Acta Pharmaceutica Sinica B. 2026;16(10):6360-6377. doi:10.1016/j.apsb.2026.07.034
BibTeX
@article{Dai2026,
author = {Dai, Yifei and Xie, Yujia and Ma, Xiaojuan and Zhang, Dong and Yang, Jiao and Lin, Kequan and Chen, Aiping and Qiang, Weijie},
title = {Antibody‒cell conjugates: A novel “off-the-shelf” modality bridging ADCs and CAR-T for cancer immunotherapy},
journal = {Acta Pharmaceutica Sinica B},
year = {2026},
volume = {16},
number = {10},
pages = {6360--6377},
doi = {10.1016/j.apsb.2026.07.034}
}
EUVIMED